ChromaCode logo

ChromaCode, Inc.

Biotechnology

ChromaCode Stock

ChromaCode is a molecular diagnostics company that develops high-definition PCR (HDPCR) technology to enhance the sensitivity and multiplexing capabilities of standard PCR instruments. Its platform enables cost-effective, high-throughput testing for infectious diseases, oncology, and genetic disorders.

For more ChromaCode stock information, or to buy or sell private shares, sign up for a MicroVentures account.

Management Team

Paul Flook President and Chief Executive Officer
Padman Sundar Chief Business Officer

Funding Information